Equity Capital Markets

Company · CIK 1836564

Valneva SE

CIK1836564 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inI0
Business addressFrance
ListedVALN (Nasdaq)
First annual or quarterly report2022-03-24

Offerings

5 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-296504
ShelfEffective
2026-06-042026-06-162
333-286071
ShelfEffective
2025-03-252025-04-022
333-266839
ShelfEffective
2022-08-122022-09-304
333-260507
IPOFinal prospectus
2021-10-262021-11-013
333-255155
IPOFinal prospectus
2021-04-092021-05-076

Filings

20
FiledFilingRegistrationAccession
2026-06-16EFFECTDeclared effective 333-2965049999999995-26-002019
2026-06-04F-3Shelf registered 333-2965040001999371-26-012100
2025-04-02EFFECTDeclared effective 333-2860719999999995-25-000949
2025-03-25F-3Shelf registered 333-2860710001999371-25-003047
2022-09-30424B5Shelf takedown 333-2668390001839882-22-022428
2022-09-29424B5Shelf takedown 333-2668390001387131-22-010106
2022-08-19EFFECTDeclared effective 333-2668399999999995-22-002457
2022-08-12F-3Shelf registered 333-2668390001839882-22-017835
2021-11-01424B4Final prospectus 333-2605070001193125-21-315379
2021-10-28EFFECTDeclared effective 333-2605079999999995-21-004086
2021-10-26F-1Registration filed 333-2605070001193125-21-308093
2021-10-20DRSDraft made public 377-056110000950123-21-013358
2021-05-07424B4Final prospectus 333-2551550001193125-21-154913
2021-05-05EFFECTDeclared effective 333-2553019999999995-21-001803
2021-05-05EFFECTDeclared effective 333-2551559999999995-21-001800
2021-05-05F-1/AAmendment 333-2551550001193125-21-150691
2021-04-29F-1/AAmendment 333-2551550001193125-21-138150
2021-04-21F-1/AAmendment 333-2551550001193125-21-124954
2021-04-09F-1Registration filed 333-2551550001193125-21-111563
2021-01-15DRSDraft made public 377-040410000950123-21-000381

All filings of this company · CSV